Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Single-Antibody Detection of T-Cell Receptor Beta Chain Monotypia Resolves Uncertainties in the Identification and Quantitation of Sézary Cells By Routine Flow Cytometry: Towards Accurate and Unequivocal Blood Staging of Cutaneous T-Cell Lymphomas

Pedro Horna, MD, Min Shi, MD PhD, Dragan Jevremovic, MD PhD, Horatiu Olteanu, MD PhD

Blood (2019) 134 (Supplement_1): 2848.

https://doi.org/10.1182/blood-2019-129477

Published: 2019

Journal Articles

Comparative Assessment of Surface CD19 and CD20 Expression on B-Cell Lymphomas from Clinical Biopsies: Implications for Targeted Therapies

Pedro Horna, MD, Grzegorz Nowakowski, MD, Jan Endell, Rainer Boxhammer

Blood (2019) 134 (Supplement_1): 5345.

https://doi.org/10.1182/blood-2019-129600

Published: 2019

Journal Articles

Recurrent Chromosomal Abnormalities in Tumoral Lesions of Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Large-Scale Fluorescent in-Situ Hybridization Study on Tissue Biopsy Sections

Pedro Horna, MD, Kathryn E. Pearce, Rhett P. Ketterling, MD, Jess Peterson, MD

Blood (2019) 134 (Supplement_1): 4282.

https://doi.org/10.1182/blood-2019-129116

Published: 2019

Journal Articles

An Analysis of a Multidisciplinary Lymphoma Virtual Tumor Board with Regional and International Participation

Thomas M. Habermann, MD, Ruth A Lentz, R.N., John J Schmitz, MD, Alexander G von Bormann, BA, Jason Young, MD, Christopher H Hunt, MD, Grzegorz S. Nowakowski, MD, Kristen McCullough, PharmD, Pedro Horna, MD, Adam J Wood, MD, William R. Macon, MD, Paul J Kurtin, MD, Scott L Stafford, MD, Usha Sree Chamarthy, MD, Faraz Khan, MD, Stephen M. Ansell, MD PhD, Rebecca L King, MD

Blood (2018) 132 (Supplement 1): 2247.

https://doi.org/10.1182/blood-2018-99-112887

Published: 2018

Journal Articles

Clinical Correlates, Prognostic Impact and Survival Outcomes in Chronic Myelomonocytic Leukemia Patients with Myeloproliferative Neoplasm Associated-Driver Mutations

Prateek Pophali, MBBS, Terra L. Lasho, PhD, Christy Finke, BS, Pedro Horna, MD, Rhett P. Ketterling, Naseema Gangat, MBBS, Kebede H. Begna, MD, Abhishek A. Mangaonkar, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD, Mrinal M. Patnaik, MD MBBS

Blood (2018) 132 (Supplement 1): 3100.

https://doi.org/10.1182/blood-2018-99-117335

Published: 2018

Journal Articles

Sézary Syndrome: Clinicopathological and Immunophenotypical Characteristics and Outcomes

Christa Roe, RN, BS, OCN, Jennifer Rock-Klotz, BA, Elyce Turba, RN, MSN, OCN, Christopher Rodriguez Salamanca, PA, Janice Bennett, MS, ARNP-C, Farrah Farquharson, PA, Sem Bastien, MS, ARNP-C, Barbara Williams, RN, BS, OCN, Rebecca Levy, MS, ARNP-C, Yibo Li, BS, Michael Montejo, MD, Ernesto Ayala, MD, Pedro Horna, MD, Lewis F Glass, MD, Rami S. Komrokji, MD, Lubomir Sokol, MD PhD

Blood (2015) 126 (23): 1546.

https://doi.org/10.1182/blood.V126.23.1546.1546

Published: 2015

Journal Articles

A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor Panobinostat (LBH589) in Addition to Glucocorticoids in Patients with Acute Graft-Versus-Host Disease

Lia Perez, MD, Teresa Field, MD PhD, Marcie L Riches, MD MS, Hugo F Fernandez, MD, Frederick L Locke, MD, Brian C Betts, MD, Joseph Pidala, MD PhD, Erika Elmer, CCRP, Francisca Beato, BS, Maritza Lienlaf, MS, Pedro Horna, MD, Alejandro Villagra, PhD, Claudio Anasetti, MD

Blood (2014) 124 (21): 1167.

https://doi.org/10.1182/blood.V124.21.1167.1167

Published: 2014

Journal Articles

Selective Inhibition of HDAC6 Decreases Viability of Cutaneous T-Cell Lymphoma and Improves Immune Recognition

Tessa Knox, MS, Maritza Lienlaf, MS, Patricio Perez-Villarroel, BS., Calvin Lee, MD, Eva Sahakian, PhD, John J. Powers, B.S., Fengdong Cheng, MD, Jorge Canales, MS, Danay Marante, MS, Ed Seto, PhD, Eduardo M. Sotomayor, MD, Alejandro Villagra, PhD, Pedro Horna, MD

Blood (2014) 124 (21): 5423.

https://doi.org/10.1182/blood.V124.21.5423.5423

Published: 2014

Journal Articles

Histone Deacetylase 11 (HDAC11) As a Novel Transcriptional Regulator of C/EBP-β, in Immature Myeloid Cell to Myeloid Derived Suppressor Cell Transition

Jie Chen, MA, Eva Sahakian, PhD, John J. Powers, B.S., Maritza LienlafMoreno, BS, Limin Xing, PhD, Susan Deng, Allison Distler, Fengdong Cheng, MD, Alejandro Villagra, PhD, Pedro Horna, MD, Eduardo M. Sotomayor, MD, Javier Pinilla-Ibarz, MD PhD

Blood (2014) 124 (21): 225.

https://doi.org/10.1182/blood.V124.21.225.225

Published: 2014

Journal Articles

Whole Genome and Exome Sequencing Defines The Genetic Landscape Of Hepatosplenic T-Cell Lymphoma

Blood (2013) 122 (21): 842.

https://doi.org/10.1182/blood.V122.21.842.842

Published: 2013

Journal Articles

A Close Association of History of Autoimmunity with Chronic Myelomonocytic Leukemia (CMML) in Contrast to Chronic Myelogenous Leukemia (CML)

Deniz Peker, MD, Eric Padron, MD, Pedro Horna, MD, John M. Bennett, MD, Xiaohui Zhang, MD, P.K. Epling-Burnette, PharmD, PhD, Jeffrey E Lancet, MD, Javier Pinilla, Lynn Moscinski, MD, Alan F. List, MD, Rami S. Komrokji, MD, Ling Zhang, MD

Blood (2012) 120 (21): 1712.

https://doi.org/10.1182/blood.V120.21.1712.1712

Published: 2012

Journal Articles

Sezary Syndrome: Clinicopathological and Immunophenotypical Characteristics and Their Impact On Survival

Darcie Deaver, MS, ARNP, Pedro Horna, MD, Lubomir Sokol, MD, Ph.D

Blood (2012) 120 (21): 5085.

https://doi.org/10.1182/blood.V120.21.5085.5085

Published: 2012

Journal Articles

The Immunomodulatory Drug Lenalidomide (CC5013; Revlimid), Enhances Antigen-Presenting Cell’s Function Leading to Effective Priming of CD4 + T-Lymphocytes.

Hongwei Wang, MD, Aung Naing, MD, Fengdong Cheng, MD, Pedro Horna, MD, Ildelfonso Suarez, PhD, Jason Brayer, PhD, Alan F. List, MD, Eduardo M. Sotomayor, MD

Blood (2005) 106 (11): 2391.

https://doi.org/10.1182/blood.V106.11.2391.2391

Published: 2005

Journal Articles

Cucurbitacins, a Family of Natural Compounds That Effectively Disrupt Stat3 Signaling in Antigen-Presenting Cells (APCs) Are Promising Agents To Overcome Tumor-Induced CD4+ T-Cell Tolerance.

Fengdong Cheng, MD, Hongwei Wang, MD, Alfonso Suarez, Pedro Horna, MD, Said Sebti, PhD, Eduardo M. Sotomayor, MD

Blood (2005) 106 (11): 1485.

https://doi.org/10.1182/blood.V106.11.1485.1485

Published: 2005

Journal Articles

Age-Related Induction of CD4 + T-Cell Unresponsiveness Is Reversible and Dependant of the Host’s Environment.

Pedro Horna, MD, Rahul Chavan, PhD, Jason Brayer, PhD, Ildefonso Suarez, BS, Eduardo M. Sotomayor, MD

Blood (2005) 106 (11): 3925.

https://doi.org/10.1182/blood.V106.11.3925.3925

Published: 2005

Journal Articles

Analysis of the Fate and Function of Antigen-Specific CD8 T Cells during B Cell Lymphoma Progression.

Jason Brayer, PhD, Fengdong Cheng, MD, Pedro Horna, MD, Ildefonso Suarez, BS, Hongwei Wang, MD, Eduardo M. Sotomayor, MD

Blood (2004) 104 (11): 80.

https://doi.org/10.1182/blood.V104.11.80.80

Published: 2004

Journal Articles

In Vivo Visualization of Stat3 Activation in Myeloid Cells during Inflammation and Tumor Growth.

Pedro Horna, MD, Fengdong Cheng, MD, Richard Jove, PhD, Linda Mora, MD, Eduardo M. Sotomayor, MD

Blood (2004) 104 (11): 3434.

https://doi.org/10.1182/blood.V104.11.3434.3434

Published: 2004

NARROW

Single-Antibody Detection of T-Cell Receptor Beta Chain Monotypia Resolves Uncertainties in the Identification and Quantitation of Sézary Cells By Routine Flow Cytometry: Towards Accurate and Unequivocal Blood Staging of Cutaneous T-Cell Lymphomas

Comparative Assessment of Surface CD19 and CD20 Expression on B-Cell Lymphomas from Clinical Biopsies: Implications for Targeted Therapies

Recurrent Chromosomal Abnormalities in Tumoral Lesions of Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia: A Large-Scale Fluorescent in-Situ Hybridization Study on Tissue Biopsy Sections

An Analysis of a Multidisciplinary Lymphoma Virtual Tumor Board with Regional and International Participation

Clinical Correlates, Prognostic Impact and Survival Outcomes in Chronic Myelomonocytic Leukemia Patients with Myeloproliferative Neoplasm Associated-Driver Mutations

Sézary Syndrome: Clinicopathological and Immunophenotypical Characteristics and Outcomes

A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor Panobinostat (LBH589) in Addition to Glucocorticoids in Patients with Acute Graft-Versus-Host Disease

Selective Inhibition of HDAC6 Decreases Viability of Cutaneous T-Cell Lymphoma and Improves Immune Recognition

Histone Deacetylase 11 (HDAC11) As a Novel Transcriptional Regulator of C/EBP-β, in Immature Myeloid Cell to Myeloid Derived Suppressor Cell Transition

Whole Genome and Exome Sequencing Defines The Genetic Landscape Of Hepatosplenic T-Cell Lymphoma

A Close Association of History of Autoimmunity with Chronic Myelomonocytic Leukemia (CMML) in Contrast to Chronic Myelogenous Leukemia (CML)

Sezary Syndrome: Clinicopathological and Immunophenotypical Characteristics and Their Impact On Survival

The Immunomodulatory Drug Lenalidomide (CC5013; Revlimid), Enhances Antigen-Presenting Cell’s Function Leading to Effective Priming of CD4 + T-Lymphocytes.

Cucurbitacins, a Family of Natural Compounds That Effectively Disrupt Stat3 Signaling in Antigen-Presenting Cells (APCs) Are Promising Agents To Overcome Tumor-Induced CD4+ T-Cell Tolerance.

Age-Related Induction of CD4 + T-Cell Unresponsiveness Is Reversible and Dependant of the Host’s Environment.

Analysis of the Fate and Function of Antigen-Specific CD8 T Cells during B Cell Lymphoma Progression.

In Vivo Visualization of Stat3 Activation in Myeloid Cells during Inflammation and Tumor Growth.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only